Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fox

Showing results (1301-1310 of 1,511) with videos related to

Pageof 152
Sort By:
Neurology|November 4, 2009
The heritability and genetics of frontotemporal lobar degenerationJ D Rohrer, R Guerreiro, J Vandrovcova, et al.
Journal of Bone Oncology|May 7, 2026
CDK4/6 inhibitor ribociclib and doxorubicin combination treatment inhibits breast cancer bone metastasis and enhances T-cell targeted therapyXinming Su, Takayuki Kobayashi, Jingyu Xiang, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 15, 2019
Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive questMartha S Foiani, Claudia Cicognola, Natalia Ermann, et al.
Alzheimer'S Research & Therapy|October 27, 2017
The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's diseaseCraig W Ritchie, Tom C Russ, Sube Banerjee, et al.
Human Brain Mapping|March 26, 2018
Cortical microstructure in young onset Alzheimer's disease using neurite orientation dispersion and density imagingThomas D Parker, Catherine F Slattery, Jiaying Zhang, et al.
The Lancet. Neurology|August 4, 2009
Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline dataSarah J Tabrizi, Douglas R Langbehn, Blair R Leavitt, et al.
Lancet (London, England)|February 7, 2026
Switch to fixed-dose doravirine (100 mg) and islatravir (0·25 mg) once daily in virologically suppressed adults with HIV-1 on oral antiretroviral therapy: 48-week results of a phase 3, multicentre, randomised, open-label, non-inferiority trialChloe Orkin, Rosie Mngqibisa, Juan Diego Velez, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|April 7, 2024
Validating the ratio of insulin like growth factor binding protein 4 to sex hormone binding globulin as a prognostic predictor of preterm birth in Viet Nam: a case-cohort studyJane E Hirst, J Jay Boniface, Dung Puhong Le, et al.
Brain : a Journal of Neurology|February 1, 2008
A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK seriesJonathan Beck, Jonathan D Rohrer, Tracy Campbell, et al.
Alzheimer'S Research & Therapy|August 1, 2018
Correction to: The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's diseaseCraig W Ritchie, Tom C Russ, Sube Banerjee, et al.
Pageof 152

Showing results (1301-1310 of 1,511) with videos related to

Sort By:
Pageof 152
Neurology|November 4, 2009
The heritability and genetics of frontotemporal lobar degenerationJ D Rohrer, R Guerreiro, J Vandrovcova, et al.
Journal of Bone Oncology|May 7, 2026
CDK4/6 inhibitor ribociclib and doxorubicin combination treatment inhibits breast cancer bone metastasis and enhances T-cell targeted therapyXinming Su, Takayuki Kobayashi, Jingyu Xiang, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 15, 2019
Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive questMartha S Foiani, Claudia Cicognola, Natalia Ermann, et al.
Alzheimer'S Research & Therapy|October 27, 2017
The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's diseaseCraig W Ritchie, Tom C Russ, Sube Banerjee, et al.
Human Brain Mapping|March 26, 2018
Cortical microstructure in young onset Alzheimer's disease using neurite orientation dispersion and density imagingThomas D Parker, Catherine F Slattery, Jiaying Zhang, et al.
The Lancet. Neurology|August 4, 2009
Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline dataSarah J Tabrizi, Douglas R Langbehn, Blair R Leavitt, et al.
Lancet (London, England)|February 7, 2026
Switch to fixed-dose doravirine (100 mg) and islatravir (0·25 mg) once daily in virologically suppressed adults with HIV-1 on oral antiretroviral therapy: 48-week results of a phase 3, multicentre, randomised, open-label, non-inferiority trialChloe Orkin, Rosie Mngqibisa, Juan Diego Velez, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|April 7, 2024
Validating the ratio of insulin like growth factor binding protein 4 to sex hormone binding globulin as a prognostic predictor of preterm birth in Viet Nam: a case-cohort studyJane E Hirst, J Jay Boniface, Dung Puhong Le, et al.
Brain : a Journal of Neurology|February 1, 2008
A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK seriesJonathan Beck, Jonathan D Rohrer, Tracy Campbell, et al.
Alzheimer'S Research & Therapy|August 1, 2018
Correction to: The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's diseaseCraig W Ritchie, Tom C Russ, Sube Banerjee, et al.
Pageof 152